Theo is completing his PharmD degree specialized in research from Université de Strasbourg, France. He is also doing a M.Sc during which he had already worked on neurobiomarkers and botulinum toxin. For his end-of-studies internship, Théo joined Guy Sauvageau’s lab to work on the characterization of compounds targeting subtypes of acute myeloid leukemia.